PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
about
Clinical and research applications of simultaneous positron emission tomography and MRIAttenuation correction for flexible magnetic resonance coils in combined magnetic resonance/positron emission tomography imaging.Clinical applications of PET/MRI: current status and future perspectives.Integrated whole body MR/PET: where are we?PET/MRI for the evaluation of patients with lymphoma: initial observations.Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.Primary Pulmonary Diffuse Large B-Cell Lymphoma on FDG PET/CT-MRI and DWIOrbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted ImagingSurveillance imaging in pediatric Hodgkin Lymphoma.Initial experience of MR/PET in a clinical cancer center.Imaging children suffering from lymphoma: an evaluation of different 18F-FDG PET/MRI protocols compared to whole-body DW-MRI.How PET/MR Can Add Value For Children With Cancer.Speeding up PET/MR for cancer staging of children and young adults.Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.MR/PET or PET/MRI: does it matter?Hybrid PET/MR: Updated Clinical Use and Potential Applications
P2860
Q26998774-F9727C52-137A-4290-A8D3-F77775A714A0Q30668738-7D699185-2C51-4F06-9E66-3AF65BB00763Q30835897-A2E2E97C-DD21-4265-A5D0-F505D8493B61Q34975185-97EE9272-115B-4BC7-8F68-0195298A056BQ35737190-68471683-B99F-48EE-B654-B80BA38F986AQ35877119-2EB45789-6F9A-40A5-9956-01BA84067ADFQ36153490-26E8BFDB-822C-4701-9AE9-3DBCDFA8028DQ36510658-E7401051-E7A2-424F-9562-DFAFC7EE7505Q36564214-94AE5586-BC4B-4395-AA20-7608E09C9EFAQ38119890-A3CD68B3-BE5A-4995-9580-9B98D0108C54Q38134357-A55A8EDF-5F5C-4F60-9225-2CE7D3DE34CAQ38680358-106B34B3-D3D6-4144-BE06-4A9F29AF5308Q39427334-0A2CA9CE-65B0-4786-BD9B-9674C2E25384Q39860692-A591B006-E6A0-4D5B-946D-727396C2018EQ41207387-39826CD1-261F-4912-9AFB-E9742B7BB89FQ43639655-099F4ED2-CACE-40D7-B53E-601418C16BDCQ58109703-0AD2B0E7-C71C-44EF-A6A6-B78480C5B320
P2860
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
@ast
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
@en
type
label
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
@ast
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
@en
prefLabel
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
@ast
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
@en
P2093
P2860
P1476
PET/MR for therapy response evaluation in malignant lymphoma: initial experience
@en
P2093
Bettina Beuthien-Baumann
Ivan Platzek
Jens Langner
Jörg Kotzerke
Jörg van den Hoff
Manuel Popp
Michael Laniado
Rainer Ordemann
P2860
P2888
P356
10.1007/S10334-012-0342-7
P577
2012-09-16T00:00:00Z